about
MicroRNAs in fibrosis: opportunities and challengesCellular Therapies in Systemic Sclerosis: Recent ProgressA Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells.Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayCD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis.Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell RegulationTh2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune featuresStrategies to overcome the hurdles to treat fibrosis, a major unmet clinical need.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesInterleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein.Role of toll-like receptors in systemic sclerosis.Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature.Tracking and treating activated T cells.Interleukin-6: a new therapeutic target in systemic sclerosis?Early systemic sclerosis-opportunities for treatment.Current frontiers in systemic sclerosis pathogenesis.Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.Genetics of systemic sclerosis.Environmental risk factors of systemic sclerosis.T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.Photopheresis: Advances and Use in Systemic Sclerosis.Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB.Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.A vitamin D analog inhibits Th2 cytokine- and TGFβ -induced periostin production in fibroblasts: a potential role for vitamin D in skin sclerosis.Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases.Increased expression and modulated regulatory activity of co-inhibitory receptors PD-1, TIGIT and TIM-3 in lymphocytes of systemic sclerosis patients.IL-17 and related cytokines involved in systemic sclerosis: Perspectives.Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis-A potential marker for histopathologic distinction from morphea.Current perspectives on the role of CD8+ T cells in systemic sclerosis.Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29).Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
P2860
Q28067380-E35C5FF6-3087-4366-82C0-740F01A3F096Q28080323-5E3F5372-DEA5-4C97-B41F-D67F5866227EQ34148693-91597DAF-EC11-415B-8B62-63F6FD396A89Q34544210-6DC0DDE6-F8FA-43AA-BC42-5B5D877896FAQ35078513-6D660012-EACF-4BDB-A878-11ECFBAE929CQ35536149-1C8D25DF-1735-4E05-AD07-E203819F9470Q36103285-0E402BB9-C8BE-406D-B0D6-93F84B07BCD8Q36260811-7BF5CE9D-265B-4720-A47C-6BACBFB6AED3Q36837811-CE146451-4A3B-4EA6-8D89-350533FB66D9Q37086513-706591A4-3BEB-4FA0-9509-5CF94233A959Q37381549-B01BDD72-6853-4A2D-8231-406523826E81Q37683419-E340B150-8F2F-4C36-AC7B-E0C2E336058BQ38132298-D9C07C29-822C-418C-BEB5-4A9C9495A6BAQ38173893-1FDA031B-2C1D-4F2C-901C-52558F2ED979Q38198637-F7EBFF7B-5A6D-4690-92E5-9DAA2F6FBE58Q38288110-727BAE11-3FEC-4DFA-B4A8-FC841479A6EDQ38364855-41A99144-78EA-4F58-AA1C-DEE4E4F5A623Q38364957-E98C0F9C-8E67-4DE8-B234-B01F12C9762EQ38366114-2F090ADB-8B3C-42CB-BE2D-A0003CC6245EQ38511454-0762105C-C386-4281-9473-554F1621AFFEQ38542589-21DCB533-338B-42AE-A551-00B0BD22C201Q38601631-E4D0173C-F408-4996-94F9-C9E14D5B2F46Q38807643-85619937-4C89-453D-83E2-D8452DC74D91Q38829051-39A80236-DEF8-4ADC-BE54-222092B271A1Q39029262-3FBC4BE7-E03B-4625-B2FC-DECE6384A816Q39129418-973E8BED-ACCD-433C-8873-984E15FEB043Q40292542-1689C512-8C96-4028-97B5-F3CBC21F56B4Q40321155-954A2570-469F-44A0-B69B-5CA441084CF5Q41223874-A928C29F-E8F1-4E01-A771-24365B54D01CQ41519827-A0EEFDD2-A291-4655-BD45-47E8721E6494Q42133154-517BAE67-729A-4D27-A315-2B7C51212AADQ42369819-B984105F-1E13-4573-939A-D611F1507CD6Q45782292-01F7DCE1-1D73-4B14-929E-EBF358A3C9FFQ47245797-2CE9ADE9-DCC8-45DB-8939-8F35F7450C5EQ47774368-2618FBB3-7E23-410F-A7E0-360AD17C0DD8Q48298768-97F0E4B3-A5B2-4B95-84BC-04C71B03612EQ49507866-F5CF38F2-0992-4205-8791-1111D2001C92Q51672074-785B73B6-AC07-474B-B034-32709ED2CA5AQ53474166-D8348D43-A31C-450C-90AE-7F7EE760AF9EQ53512767-ABE54D6F-F519-4B4A-9107-E5DAAEB43765
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
T cells in systemic sclerosis: a reappraisal.
@en
type
label
T cells in systemic sclerosis: a reappraisal.
@en
prefLabel
T cells in systemic sclerosis: a reappraisal.
@en
P2093
P2860
P356
P1433
P1476
T cells in systemic sclerosis: a reappraisal.
@en
P2093
Jacob M van Laar
Steven O'Reilly
Thomas Hügle
P2860
P304
P356
10.1093/RHEUMATOLOGY/KES090
P577
2012-05-09T00:00:00Z